These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3044918)

  • 1. Domperidone.
    Champion MC
    Gen Pharmacol; 1988; 19(4):499-505. PubMed ID: 3044918
    [No Abstract]   [Full Text] [Related]  

  • 2. Domperidone, a new dopamine antagonist.
    Champion MC; Hartnett M; Yen M
    CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domperidone: a peripherally acting dopamine2-receptor antagonist.
    Barone JA
    Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine antagonist domperidone (Motilium) in everyday clinical practice.
    Udvardi G
    Ther Hung; 1988; 36(4):206-9. PubMed ID: 3253964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastritis, stomach ulcer, reflux diseases. Motility effective therapy with Motilium].
    Heinkelein J
    ZFA (Stuttgart); 1982 Jun; 58(18):1028-30. PubMed ID: 7113397
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.
    Davis RH; Clench MH; Mathias JR
    Dig Dis Sci; 1988 Dec; 33(12):1505-11. PubMed ID: 3058442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pro-kinetic agents. Developments and indications].
    Layer P
    Z Gastroenterol Verh; 1991 Mar; 26():157-8. PubMed ID: 1714133
    [No Abstract]   [Full Text] [Related]  

  • 8. Domperidone in reflux oesophagitis and gastric stasis.
    Schulze-Delrieu K; Summers RW; Finke D
    Lancet; 1981 Jan; 1(8212):159. PubMed ID: 6109839
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine antagonists in the upper gastrointestinal tract.
    Valenzuela JE; Dooley CP
    Scand J Gastroenterol Suppl; 1984; 96():127-36. PubMed ID: 6382574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations with dopamine antagonist domperidone (Motilium) in controlling postoperative dyspepsias and vomiting.
    Horváth I
    Ther Hung; 1987; 35(2):89-93. PubMed ID: 3438869
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of peripheral dopamine antagonist (Motilium) in the treatment of dyspeptic complaints of different origin and in nausea, vomiting.
    Sásdi A
    Ther Hung; 1989; 37(3):172-5. PubMed ID: 2588201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.
    Reyntjens AJ; Niemegeers CJ; Van Nueten JM; Laduron P; Heykants J; Schellekens KH; Marsboom R; Jageneau A; Broekaert A; Janssen PA
    Arzneimittelforschung; 1978; 28(7):1194-6. PubMed ID: 582708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domperidone.
    Cherian S; Sachdev HP; Puri RK
    Indian Pediatr; 1989 Sep; 26(9):932-5. PubMed ID: 2699318
    [No Abstract]   [Full Text] [Related]  

  • 14. Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting.
    Van Outryve M; Lauwers W; Verbeke S
    Postgrad Med J; 1979; 55 Suppl 1():33-5. PubMed ID: 382152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.
    Cann PA; Read NW; Holdsworth CD
    Gut; 1983 Dec; 24(12):1135-40. PubMed ID: 6357963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domperidone: an alternative to metoclopramide.
    Drug Ther Bull; 1988 Jul; 26(15):59-60. PubMed ID: 3208664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Motility-effective drugs for therapy of gastrointestinal functional disorders].
    Weihrauch TR; Kilbinger H
    Dtsch Med Wochenschr; 1982 Sep; 107(35):1323-8. PubMed ID: 6749465
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine and domperidone in the treatment of Parkinson disease.
    Quinn N; Illas A; Lhermitte F; Agid Y
    Neurology; 1981 Jun; 31(6):662-7. PubMed ID: 7195483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations.
    Buffery PJ; Strother RM
    N Z Med J; 2015 Jun; 128(1416):66-74. PubMed ID: 26117678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of domperidone (Motilium) in controlling postoperative nausea and vomiting.
    Lencz L
    Ther Hung; 1990; 38(3):106-9. PubMed ID: 2284618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.